NOTCH1 and acute lymphoblastic leukemia: The NOTCH1 signaling pathway is critical for thymocyte development and is also a major oncogenic driver in T-ALL, with activating NOTCH1 mutations detected in approximately 60% of T-ALL patients (Radtke et al., 2004; Weng et al., 2004).